Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Notes underwriting agrmnt

NEUROPATHIX, INC. (KLFE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/12/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/23/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/16/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
11/12/2021 10-Q Quarterly Report for the period ended September 30, 2021
09/28/2021 8-K Quarterly results
08/06/2021 10-Q Quarterly Report for the period ended June 30, 2021
07/06/2021 EFFECT Form EFFECT - Notice of Effectiveness:
06/23/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/13/2021 10-Q Quarterly Report for the period ended March 31, 2021
03/30/2021 10-K Annual Report for the period ended December 31, 2020
03/17/2021 8-K Quarterly results
02/23/2021 D Form D - Notice of Exempt Offering of Securities:
02/23/2021 8-K Quarterly results
12/21/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Intellectual Property Rights Purchase and Transfer Agreement",
"Pharmaceutical Royalty Agreement",
"Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate"
11/19/2020 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Binding Letter of Intent",
"Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property"
11/12/2020 10-Q Quarterly Report for the period ended September 30, 2020
11/06/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Amendment, filed on November 4, 2020",
"Kannalife, Inc. Rebrands as Neuropathix, Inc.; Reveals New Name, Ticker Symbol, Updated Logo and Visual Identity"
10/05/2020 EFFECT Form EFFECT - Notice of Effectiveness:
09/22/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Equity Purchase Agreement, by and between the Company and Investor"
09/22/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/12/2020 10-Q Quarterly Report for the period ended June 30, 2020
06/29/2020 8-K Quarterly results
06/11/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Securities Purchase Agreement",
"Form of Convertible Promissory Note",
"Form of Irrevocable Transfer Agent Letter",
"Form of Warrant"
05/14/2020 10-Q Quarterly Report for the period ended March 31, 2020
04/10/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger by and among Bio-Matrix Scientific Group, Inc., Rivulet Films LLC, and Rivulet Films, Inc.",
"Rivulet Films Merges with Bio-Matrix Scientific Group, Inc. NEW Rivulet Media to Fund Film Productions Using Proprietary Financing Model April 9, 2020 - Gilbert, AZ - Rivulet Films’ Executives Aaron Klusman and Mike Witherill are announcing a merger with publicly traded Bio-Matrix Scientific Group, Inc. , intending to rename Bio-Matrix as Rivulet Media. The company will produce films using a proprietary financing model to deliver studio quality, star driven content in what management believes is a more efficient way."
04/10/2020 8-K Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain O...
03/30/2020 10-K Annual Report for the period ended December 31, 2019
03/18/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Securities Purchase Agreement",
"Form of Convertible Promissory Note",
"Form of Irrevocable Transfer Agent Letter"
01/28/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Stockholder Letter",
"Kannalife, Inc. CEO Recaps 2019 Advances and Potential Ahead"
01/14/2020 D Form D - Notice of Exempt Offering of Securities:
11/13/2019 10-Q Quarterly Report for the period ended September 30, 2019
08/13/2019 10-Q Quarterly Report for the period ended June 30, 2019
08/13/2019 EFFECT Form EFFECT - Notice of Effectiveness:
08/08/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy